Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Publication
, Journal Article
Piccini, JP; Jones, WS
Published in: N Engl J Med
February 1, 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
February 1, 2018
Volume
378
Issue
5
Start / End Page
486
Location
United States
Related Subject Headings
- Warfarin
- Stroke
- Percutaneous Coronary Intervention
- Humans
- General & Internal Medicine
- Fibrinolytic Agents
- Dabigatran
- Atrial Fibrillation
- Anticoagulants
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., & Jones, W. S. (2018). Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med, 378(5), 486. https://doi.org/10.1056/NEJMc1715183
Piccini, Jonathan P., and W Schuyler Jones. “Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.” N Engl J Med 378, no. 5 (February 1, 2018): 486. https://doi.org/10.1056/NEJMc1715183.
Piccini JP, Jones WS. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2018 Feb 1;378(5):486.
Piccini, Jonathan P., and W. Schuyler Jones. “Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.” N Engl J Med, vol. 378, no. 5, Feb. 2018, p. 486. Pubmed, doi:10.1056/NEJMc1715183.
Piccini JP, Jones WS. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2018 Feb 1;378(5):486.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
February 1, 2018
Volume
378
Issue
5
Start / End Page
486
Location
United States
Related Subject Headings
- Warfarin
- Stroke
- Percutaneous Coronary Intervention
- Humans
- General & Internal Medicine
- Fibrinolytic Agents
- Dabigatran
- Atrial Fibrillation
- Anticoagulants
- 42 Health sciences